We are dedicated to funding cutting-edge research to discover therapeutic strategies to alleviate all the symptoms of Angelman Syndrome. Our goal is to bring practical treatment to medical practice as quickly as possible.
|
Published Research
In 1997 UBE3A was identified as the causative gene for Angelman Syndrome; this discovery formed the basis for many research projects, each on increasing understanding and moving closer toward a therapeutic. Search research by human or animal studies and subcategories including diagnostics, behaviour, genetics, biochemistry, seizure, sleep disorders and health care .... read more (for recently published research visit our news and events page)
|
|
Research Timeline
In 1965 Dr Harry Angelman first described the syndrome, in 1997 UBE3a is identified as the critical gene, 2007 deficits rescued in the mouse model....see the landmarks in AS research over the years.
|
|
The Scientists
Our Scientific Advisory Board was established to provide professional advice on current and future scientific programs; ensuring they are both beneficial and relevant to our goals. Comprised of Australian and United States researchers, members of the FAST Australia Scientific Advisory Board generously volunteer their time and expertise. ..awetgawehgweha
|
|
Our Research
Despite Angelman Syndrome developments advancing at great speed internationally, research in Australia has been minimal; hence the formation of FAST Australia. Australia has a reputation for a number of notable scientific discoveries and our scientists have a lot to offer the international search for a therapeutic for Angelman Syndrome.
We are proud to announce our first research project in partnership with the Mater Hospital and Mater Medical Research Institute, the Angelman Syndrome Register. The study will be a “first of its kind” register of AS patients and related medical professionals who can be contacted in the event of the development, participation in a study, a therapeutic or a cure. Captured information will empower the community of families affected by Angelman Syndrome community by providing a wide-ranging collection of relevant data on the syndrome. Join the Angelman Syndrome Register here....
FAST Australia will continue to raise funds and promote collaborative research in Australia until a therapeutic to treat Angelman Syndrome is discovered and used in practice for all affected individuals.
|
